Skip to content

Clinical trials

Plaque, Atherosclerotic trials with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Plaque, Atherosclerotic Phase: Not applicable Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20151
20173
20191
20211
20221
20232
20244
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting4
Active, not recruiting2
Unknown status2
Not yet recruiting1
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assistance Publique Hopitaux De Marseille2
Barts & The London NHS Trust1
BrosMed Medical Co., Ltd1
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer1
Centre Hospitalier Universitaire de Nīmes1
Federal University of Rio Grande do Sul1
Icahn School of Medicine at Mount Sinai1
Korea University Guro Hospital1
Linkoeping University1
Prof. Maurovich-Horvat Pál1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Plaque, Atherosclerotic17
Coronary Artery Disease6
Atherosclerosis4
Carotid Artery Diseases3
Carotid Stenosis3
Cardiovascular Diseases2
Lung Neoplasms2
Acute Coronary Syndrome1
Aortic Valve Stenosis1
Arteriosclerosis1

Trials

Showing 76 to 17 of 17. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.